No Data
No Data
No Data
No Data
No Data
Zivo Bioscience (ZIVO) Gets a Buy From Maxim Group
TipRanksApr 12 07:36 ET
Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets
TipRanksFeb 15 17:07 ET
ZIVO Bioscience Reports Additional Findings From Positive 42-Day Coccidiosis Challenge Study
Reduction in intestinal damage enables poultry farms to optimize feed utilizationBLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO) (the "Company"), a biotech/agtech R&D com
BusinesswireFeb 7 16:54 ET
ZIVO Bioscience Announces Uplisting to OTCQB Market
Zivo Bioscience, Inc. (OTCQB: ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces it has uplisted the trading of shares of its common stock from the OTC Pink Market to the OTCQB Venture Market (OTCQB), effective as of the opening of trading on Friday, January 26, 2024
BusinesswireJan 29 08:00 ET
Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)
TipRanksJan 25 08:00 ET
ZIVO Bioscience Reports Positive Efficacy Results From 42-Day Validation Study With Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTC PINK: ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional prod
BusinesswireJan 23 08:00 ET
No Data
No Data